INMB vs REGN: Which Stock is Better?
Side-by-side comparison of Inmune Bio Inc and Regeneron Pharmaceuticals Inc in 2026
INMB
Inmune Bio Inc
$1.29
REGN
Regeneron Pharmaceuticals Inc
$742.08
Key Metrics Comparison
| Metric | INMB | REGN | Winner |
|---|---|---|---|
| Market Cap | $33.50M | $79.87B | REGN |
| P/E Ratio | N/A | 18.21 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | 2.6% | 0.0% | INMB |
| Gross Margin | 100.0% | 44.6% | INMB |
Analyze INMB
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INMB or REGN a better investment?
Comparing INMB and REGN: Inmune Bio Inc has a market cap of $33.50M while Regeneron Pharmaceuticals Inc has $79.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INMB and REGN?
INMB (Inmune Bio Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INMB or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INMB or REGN?
INMB has higher revenue growth at 2.6% vs 0.0% for REGN.
Which company is more profitable: INMB or REGN?
Inmune Bio Inc (INMB) has higher gross margins at 100.0% compared to 44.6% for REGN.
Which is the larger company: INMB or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.87B compared to $33.50M for INMB.
Should I buy INMB or REGN in 2026?
Both INMB and REGN have investment merit. INMB trades at $1.29 while REGN trades at $742.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INMB and REGN stock?
Key differences: Market Cap ($33.50M vs $79.87B), P/E Ratio (N/A vs 18.2x), Revenue Growth (2.6% vs 0.0%), Gross Margin (100.0% vs 44.6%).